RECRUITING

Preventing T2DM After GDM With Immediate Postpartum Screening

Conditions

Gestational Diabetes Type 2 Diabetes diabetes

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overall goal of this proposal is to create and test an implementation protocol for in-hospital immediate postpartum diabetes screening for postpartum patients with pregnancies affected by GDM.

Official Title

Preventing Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus With Immediate Postpartum Screening

Quick Facts

Study Start:2025-06-01

Study Completion:2028-12-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06457139

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:FEMALE

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* pregnancy complicated by GDM as diagnosed with traditional two step testing in the third trimester according to Carpenter-Coustan Criteria * receiving prenatal care at UMASS Memorial and plans to deliver at UMASS Memorial * able and willing to provide informed consent * ability to complete immediate in hospital postpartum glucose testing * have evidence of impaired glucose metabolism defined as fasting glucose value of ≥126 mg/dL or 2-hour glucose value of ≥200 mg/dL	* known diagnosis of pre-existing pre-gestational diabetes in pregnancy * inability to complete oral glucose tolerance test (e.g. gastric bypass surgery history, gastric dumping syndrome history, vomiting of oral glucose tolerance test) in pregnancy or immediately postpartum * systemic steroid use

Inclusion Criteria

Exclusion Criteria

* pregnancy complicated by GDM as diagnosed with traditional two step testing in the third trimester according to Carpenter-Coustan Criteria
* receiving prenatal care at UMASS Memorial and plans to deliver at UMASS Memorial
* able and willing to provide informed consent
* ability to complete immediate in hospital postpartum glucose testing
* have evidence of impaired glucose metabolism defined as fasting glucose value of ≥126 mg/dL or 2-hour glucose value of ≥200 mg/dL

* known diagnosis of pre-existing pre-gestational diabetes in pregnancy
* inability to complete oral glucose tolerance test (e.g. gastric bypass surgery history, gastric dumping syndrome history, vomiting of oral glucose tolerance test) in pregnancy or immediately postpartum
* systemic steroid use

Contacts and Locations

Study Contact

Gianna Wilkie, MD

CONTACT

508-3444982

Gianna.Wilkie@umassmemorial.org

Principal Investigator

Gianna Wilkie, MD

PRINCIPAL_INVESTIGATOR

UMASS Memorial Healthcare

Study Locations (Sites)

University of Massachusetts Memorial Medical Center

Worcester, Massachusetts, 01605

United States

Collaborators and Investigators

Sponsor: University of Massachusetts, Worcester

Gianna Wilkie, MD, PRINCIPAL_INVESTIGATOR, UMASS Memorial Healthcare

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06-01

Study Completion Date2028-12-01

Study Record Updates

Study Start Date2025-06-01

Study Completion Date2028-12-01

Terms related to this study

Keywords Provided by Researchers

diabetes

Additional Relevant MeSH Terms

Gestational Diabetes
Type 2 Diabetes